Oruka Therapeutics, Inc.
ORKA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000907654
In the last 90 days, Oruka Therapeutics, Inc. insiders filed 0 open-market purchases and 16 sales; 255 institutions reported holding it in 13F filings for Q2 2026, worth $7.05B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Oruka Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +4 vs. Q4 2022
- Shares held
- 2.52M
- −91.1K (−3.5%) vs. Q4 2022
- Total value
- $5.02M
- −$1.17M (−18.9%) vs. Q4 2022
- New holders
- 5
- 9 more added
- Sold out
- 1
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORKA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 255 | $7.05B |
| Q1 2026 | 184 | $2.55B |
| Q4 2025 | 143 | $1.60B |
| Q3 2025 | 105 | $875.8M |
| Q2 2025 | 81 | $386.0M |
| Q1 2025 | 71 | $326.1M |
| Q4 2024 | 66 | $606.6M |
| Q3 2024 | 42 | $604.2M |
| Q2 2024 | 32 | $49.4M |
| Q1 2024 | 23 | $12.7M |
| Q4 2023 | 25 | $12.7M |
| Q3 2023 | 21 | $6.55M |
| Q2 2023 | 23 | $5.75M |
| Q1 2023 | 26 | $5.02M |
| Q4 2022 | 22 | $6.19M |
| Q3 2022 | 25 | $4.58M |
| Q2 2022 | 24 | $4.17M |
| Q1 2022 | 22 | $2.60M |
| Q4 2021 | 21 | $2.41M |
| Q3 2021 | 19 | $4.53M |
| Q2 2021 | 17 | $4.16M |
| Q1 2021 | 17 | $3.20M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Oruka Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 31 | $62 | 0.00% | −34−52.3% | Reduced |
| Barclays PLC | 49 | $98 | 0.00% | +49 | New |
| Advisor Group Holdings, Inc. | 57 | $113 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 100 | $199 | 0.00% | +2+2.0% | Added |
| Parallel Advisors, LLC | 244 | $486 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 300 | $597 | 0.00% | +300 | New |
| TD Waterhouse Canada Inc. | 1,300 | $2.54K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,787 | $3.56K | 0.00% | +285+19.0% | Added |
| Tower Research Capital LLC (TRC) | 2,991 | $6.00K | 0.00% | +1,519+103.2% | Added |
| HRT Financial LP | 14,408 | $28.0K | 0.00% | +14,408 | New |
| Charles Schwab Investment Management Inc | 14,988 | $29.8K | 0.00% | +14,988 | New |
| Marquette Asset Management, LLC | 17,318 | $34.5K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 20,982 | $41.8K | 0.00% | +3,465+19.8% | Added |
| Group One Trading, L.P. | 23,000 | $45.8K | 0.00% | +23,000 | New |
| Citadel Advisors LLC | 25,211 | $50.2K | 0.00% | +19,730+360.0% | Added |
| Tekla Capital Management LLC | 32,461 | $64.6K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 39,700 | $79.0K | 0.00% | +4,500+12.8% | Added |
| Dimensional Fund Advisors LP | 42,502 | $84.6K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 46,948 | $93.4K | 0.00% | 00.0% | Unchanged |
| Murchinson Ltd. | 52,800 | $100.7K | 0.02% | +2,207+4.4% | Added |
| State Street Corp | 71,637 | $142.6K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 155,635 | $309.7K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 264,731 | $526.8K | 0.00% | +1,050+0.4% | Added |
| Vanguard Group Inc | 467,205 | $929.7K | 0.00% | +7,800+1.7% | Added |
| Newtyn Management, LLC | 519,765 | $1.03M | 0.20% | −18,513−3.4% | Reduced |
| BML Capital Management, LLC | 706,930 | $1.41M | 1.22% | −151,326−17.6% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −14,578−100.0% | Sold out |